ArticleJournal of cancer research and clinical oncology2015

Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status.

Xiaoxi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.